TCP Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,117
Closed -$255K 134
2025
Q4
$255K Buy
1,117
+48
+4% +$10.9K 0.04% 88
2025
Q3
$248K Buy
+1,069
New +$218K 0.04% 92
2025
Q2
Sell
-1,054
Closed -$221K 94
2025
Q1
$221K Buy
+1,054
New +$205K 0.05% 82
2024
Q4
Sell
-1,226
Closed -$242K 92
2024
Q3
$242K Buy
+1,226
New +$229K 0.06% 75
2024
Q2
Sell
-1,158
Closed -$211K 76
2024
Q1
$211K Buy
+1,158
New +$200K 0.06% 73

Other funds holding ABBV

TCP Asset Management's ABBV Position: Q1 2026 in Review

TCP Asset Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,117 shares — an estimated $255K sold.

TCP Asset Management first reported a position in ABBV in Q1 2024 and held it in 5 quarters. The position peaked at $255K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • TCP Asset Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • TCP Asset Management sold 1,117 AbbVie shares in Q1 2026, an estimated $255K.
  • TCP Asset Management first reported a position in AbbVie in Q1 2024 and held it in 5 quarters.
  • TCP Asset Management's AbbVie position peaked at $255K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on TCP Asset Management's 13F filing for Q1 2026, filed 10 Apr 2026.